For patients with Crohn disease and ulcerative colitis, a fixed-dose co-antibody therapy targeting interleukin-23p19 subunit and tumor necrosis factor-α, JNJ-78934804 is efficacious.

The United States has recorded more measles cases this year than in any year since 1991, with more than five months ...

From 2017 to 2022, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) more than doubled, according to a ...

Nearly 1.6 million dozen eggs sold across the South and Southwest are being recalled because they may be contaminated ...

For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to admini ...

Many U.S. schools aren’t well prepared to help students who’ve suffered a concussion, a new study says.A quarter of p ...

Country of birth can play a part in Black Americans' stroke risk, according to a new study.The study — published July 1 ...

Here's some welcome news for coffee lovers. Drinking as many as five cups of caffeinated coffee a day is generall ...

Insurance denials of first attempts to fill brand-name prescription drugs with no generic competitors increased more t ...

Artificial intelligence simulations of the dead are already a reality. Services like HereAfterAI, Project Decem ...

Significant changes in voice are observed during an exacerbation of asthma or chronic obstructive pulmonary disease ...

Do you have sleep apnea, but find CPAP machines too uncomfortable or noisy?A pacemaker for the tongue might help impr ...